Medical devices maker Cook Medical has obtained a contract from healthcare performance improvement company Vizient for the delivery of endoscopy devices.
Under the contract, Cook Medical will continue to deliver endoscopy devices to Vizient member healthcare facilities.
Go deeper with GlobalData
With this contract, the company intends to make its endoscopy products more accessible for physicians and patients throughout the US.
The new agreement is effective from 1 April this year and covers Cook’s full line of endoscopy medical devices, including the Hemosprayendoscopic hemostat.
The contract will further cover products from several categories, including biliary access (long wire and short wire), biopsy, cytology and polypectomy, extraction, dilation, drainage stenting, biliary/pancreatic therapy, stricture management and tissue management.
The categories also comprise oesophagal, gastric, colonic, haemostasis, enteroscopy, endoscopic ultrasound, endobronchial ultrasound, endohaepatology and endosurgery.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataCook Medical national GPO account executive Rick Simms said: “We are honoured to have been chosen as an endoscopy contracted supplier with Vizient.
“With over 40 years of expertise in the gastroenterology speciality, Cook Medical looks forward to continuing to work with Vizient members and the physicians that treat patients with our endoscopy medical devices.”
Established in 1963, Cook Medical is focused on the development of technologies for the elimination of open surgery.
In February last year, CooperCompanies reached a binding agreement for the acquisition of the Reproductive Health business from Cook Medical in a deal valued at around $875m.
The Reproductive Health business produces minimally invasive medical devices for fertility, gynaecology, obstetrics, assisted reproductive technology (ART), and in vitro fertilisation (IVF).
